Correlation of the Schirmer 1 and Fluorescein Clearance Tests With the Severity of Corneal Epithelial and Eyelid Disease

Abstract

Objective: To evaluate the correlations of the fluorescein clearance test (FCT) and the Schirmer 1 test with the severity of corneal epithelial and eyelid disease in normal patients and patients with tear film disorders due to meibomian gland disease (MGD) and/or aqueous tear deficiency (ATD).Methods: Nineteen normal control subjects, 16 patients with MGD associated with rosacea, 21 patients with noninflammatory atrophic MGD, and 43 patients with ATD were enrolled. There was a similar age and sex distribution in each group. Each patient completed a symptom severity questionnaire that consisted of 11 questions and then underwent a panel of diagnostic tests in the following order: assessment of corneal and conjunctiva sensation with the Cochet-Bonnet esthesiometer, FCT, assessment of corneal fluorescein staining, Schirmer 1 test (5 minutes without anesthesia), and biomicroscopic examination of the eyelid margins and meibomian glands. The FCT was performed with a fluorophotometer by measuring the fluorescein concentration in minimally stimulated tear samples collected from the inferior tear meniscus. By studying the best area under the receiver operating characteristic curves, we developed a formula that combined the FCT and Schirmer test results, which we termed the FCT corrected by Schirmer test. Results:The FCT showed stronger correlation with ocular irritation symptoms (r=0.35, P Ͻ.001), corneal fluorescein staining (r=0.54, PϽ.001), and meibomian gland and eyelid pathologic signs than the Schirmer 1 test. A correction factor that was based on the best area under the receiver operating characteristic curves, added to the FCT score, improved its correlation with ocular irritation symptoms, eyelid margin and meibomian gland pathologic signs, and ocular surface sensitivity scores.Conclusions: Corneal epithelial disease is correlated with decreased aqueous tear production and delayed tear clearance, whereas eyelid and MGD are correlated with delayed tear clearance. The FCT corrected by Schirmer 1 test improves the correlations of the FCT with ocular irritation symptoms, corneal epithelial and eyelid pathologic signs, and corneal and conjunctival sensitivity for patients with MGD and ATD.

Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study

“…Blepharitis was graded using a scoring system developed following the review of the literature [4,[23][24][25][26][27][28][29] . Six features of anterior blepharitis (grease, skin scales, collarettes, frank ulcers, loss of lashes and inflammation) and 6 features of posterior blepharitis (cheesy secretions, more than one third of meibomian glands blocked, telangiectasia, meibomitis, notched lid margin and active chalazia) were chosen.…”

Ojo seco y calidad de vida

“…Además hay que dejar tiempo entre la gota y el test para minimizar el lagrimeo reflejo producido por la sensación de escozor. Por otra parte, muchos pacientes con Schirmer bajos tienen pocos síntomas, mientras que otros con una moderada secreción lagrimal pueden desarrollar queratoconjuntivitis sicca grave (6).…”

Análise do custo-benefício da avaliação ocular de pacientes portadores de rosácea

“…Esta quantidade diminui com a idade, mas provavelmente não deverá ser menor do que 10 mm (4) . Na literatura, encontramos alguns estudos apresentando teste de Schirmer normal em pacientes com rosácea (13,(16)(17) ; também encontramos estudo (5) com valores de Schirmer I mais baixos em pacientes com rosácea ocular comparados com o grupo controle. Os pacientes deste estudo apresentaram testes com valores normais em 75% dos olhos, com significância estatística.…”